Clinical Newsletter
Regular updates on our latest clinical studies.
Our research and development teams operate at a global level and generate synergies from our collective expertise and by drawing on related disciplines. We are also constantly exchanging information at an international level with independent technical institutions, key opinion leaders and multipliers in order to be able to ensure cooperation and knowledge management of the highest order. As part of this process, we also conduct extensive research, the results of which we continually present in workshops, at conferences and symposiums - either in documentation or talks given by our cooperation partners - and also publish in renowned scientific journals. This database contains a large number of these evidence-based scientific articles, most of which have been evaluated by independent assessors:
This article reports an observational evaluation of 19 patients with highly exuding wounds. Flivasorb was used as a super absorbent dressing that could remove the harmful exudate fluid and promote a healthy wound bed. The outcomes demonstrated that Flivasorb is successfully absorbs large amounts of fluid, reduces the number of dressing changes required and therefore, reduces the cost of the patient's care.
Polyhexamethylene biguanide (PHMB) has been available as a wound irrigation fluid in Europe for some time. Recently, it has been successfully introduced into wound management within a range of dressings, including non-adherent products, gauze, drains, intravenous sponges and hydrogels. In some cases, the PHMB molecule has been chemically bound to the base material, providing it with antiseptic/antimicrobial properties when in contact with wound moisture. In other products, the active component is free to be delivered into the wound and periwound tissues, serving as a carrier for a wider antimicrobial activity by donating PHMB to the wound surfa
BACKGROUND
It is widely believed that the loss of compression pressure of inelastic bandages is associated with a loss of efficacy in contrast to elastic material, which maintains its pressure and performance. This study compared the effect exerted by inelastic bandages vs elastic compression stockings on the venous pumping function in patients with severe superficial venous insufficiency immediately after application and 1 week later.
METHODS
Ejection fraction (EF) of the calf pump was measured in 18 patients presenting with bilateral reflux in the great saphenous vein (CEAP C(3)-C(5)) without any compression and immediately after application of an inelastic bandage on one leg and an elastic compression stocking on the other leg. Measurements were repeated 1 week later, before compression removal. EF was measured using a plethysmographic technique. The changes of interface pressure of the applied compression products were recorded simultaneously with EF measurements.
RESULTS
After application, bandages and stockings achieved a significant improvement of EF (P < .001) that was much more pronounced in the bandaged legs. The median resting pressure was 45 mm Hg (interquartile range, 41-48.5 mm Hg) under the stockings and 64.5 mm Hg (interquartile range, 51-80 mm Hg) under the bandages. After 1 week, EF was still significantly improved in the bandaged leg (P < .001), but not under the stockings. At this time, the pressure under the stockings was only slightly reduced (5.9% supine, 3.6% standing), but the mean pressure loss under the bandages was much higher (54.3% supine, 35.4% standing).
CONCLUSION
The findings supporting inelastic compression are important in explaining the benefits of its use in chronic venous insufficiency. Inelastic bandages maintain their superior efficacy on the venous pumping function after a wearing time of 1 week, despite a significant loss of pressure.